Ideal Option Report Shows 96% Opioid Abstinence in Long-Term Recovery

Ideal Option, a provider of outpatient medication-assisted treatment (MAT) for addiction, has released its 2025 Annual Outcomes Report for New Mexico patients. The report, which aggregates data from over 750 patients, highlights treatment stages, medication adherence, and substance use trends.

The report emerges as New Mexico faces a worsening overdose crisis. Federal data from the CDC indicates that the state was among a few where overdose deaths rose in 2025, contrasting with a national decline. New Mexico Department of Health data also show a reversal of a downward trend in overdose-related emergency room visits.

The situation is particularly acute in northern New Mexico. A recent report by State Auditor Joseph Maestas found significant increases in overdose deaths in Rio Arriba, Santa Fe, and Taos counties during the first half of 2025, with fentanyl identified as a primary factor.

Key findings from Ideal Option's report demonstrate the effectiveness of its office-based MAT. Among patients in long-term recovery, 96% achieved sustained abstinence from opioids. For patients progressing from treatment initiation to maintenance in 2025, the report noted a 99% reduction in fentanyl use and an 88% reduction in methamphetamine use.

Ideal Option has been providing treatment since 2019 and has assisted over 100,000 patients across more than 80 clinics in nine states. The company accepts most insurance and aims for rapid treatment initiation.